Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | PAR 25 066

FAQs: Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) - PAR-25-066

What is this funding opportunity?

This is a National Institutes of Health (NIH) discretionary grant opportunity titled "Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" under Funding Opportunity Number PAR-25-066 (CFDA 93.242). It supports research on late-life suicide risk as it relates to social disconnection, including both social isolation and loneliness, with an emphasis on mechanisms and prevention.

What is the main goal of the program?

The goal is to improve understanding of how social disconnection contributes to suicidal thoughts and behaviors in older adults and to use that knowledge to prevent suicide. NIH is prioritizing projects that move beyond documenting associations and instead clarify why risk increases for some older adults, through what pathways, and under what conditions.

Who is the target population for this opportunity?

The focus is on older adults (late life) and suicide risk in this population, including suicidal ideation, suicidal behaviors, and related risk processes that can be influenced by social disconnection.

How does NIH define "social disconnection" in this announcement?

The announcement draws a clear distinction between objective social isolation and perceived social isolation. Objective social isolation refers to limited social contacts or infrequent social interaction. Perceived social isolation is commonly described as loneliness.

What is the difference between objective social isolation and loneliness, and why does it matter here?

Objective social isolation is about the measurable quantity or frequency of social contact (for example, how often someone interacts with others). Loneliness is about how isolated a person feels, regardless of how many contacts they have. NIH is emphasizing this distinction because these two forms of disconnection may affect suicide risk through different mechanisms and may require different intervention targets.

What types of research questions fit this opportunity?

Projects should aim to clarify how social isolation and/or loneliness contribute to late-life suicidal thoughts and behaviors, identify actionable mechanisms that explain risk, and generate knowledge that can inform prevention-oriented interventions or service models that strengthen social connection.

Is the focus mainly on describing correlations between isolation/loneliness and suicide?

No. The emphasis is not simply on documenting correlations. NIH is looking for studies that pinpoint mechanisms and actionable pathways that help explain why social disconnection becomes dangerous for some older adults and when risk escalates.

What does NIH mean by focusing on "mechanisms"?

Mechanism-focused research aims to identify the neurobiological and environmental pathways through which social isolation and loneliness increase suicide risk in late life. This includes studying how biological processes and contextual factors interact to elevate risk.

What kinds of neurobiological pathways are mentioned as relevant?

The opportunity explicitly encourages research that examines brain-related processes, stress-related processes, inflammatory processes, and other biological mechanisms that may link social disconnection to suicide risk.

What kinds of environmental or contextual factors are mentioned as relevant?

Examples highlighted include bereavement, caregiving burdens, reduced mobility, chronic illness, disability, poverty, discrimination, and barriers to accessing supportive services. Applicants can study how these factors contribute to risk and interact with social isolation or loneliness.

What is an "experimental therapeutics approach" in the context of this grant?

An experimental therapeutics approach means proposals should be organized around identifying measurable intervention targets, developing or refining interventions that engage those targets, and testing whether changing the target also changes suicide-related outcomes.

What are examples of intervention targets or strategies that could fit?

The announcement gives examples such as strategies to reduce loneliness, increase meaningful social contact, improve perceived belonging, address maladaptive social cognition, or mitigate biological stress responses linked to isolation, while explicitly tracking effects on suicide-related outcomes.

Do projects need to measure suicide-related outcomes directly?

The announcement indicates an expectation that studies track effects on suicide-related outcomes such as suicidal ideation, self-harm risk factors, or related clinical endpoints, especially when testing interventions and targets.

Are clinical trials required?

No. The funding opportunity is designated "clinical trial optional," meaning applicants may propose either clinical trials or non-trial studies, depending on what best fits the research question and stage of research.

If a project does include a clinical trial, what would NIH want to see?

Based on the emphasis described, a trial would typically be expected to test an intervention that engages a measurable target (for example, loneliness or a biological stress response) and to evaluate whether changing that target leads to improvement in suicide-related outcomes or closely related clinical endpoints.

What is the role of service delivery innovation in this opportunity?

Service delivery innovation is highlighted as a key avenue for impact. NIH is interested in research that develops new service models or modifies existing models to strengthen social connection in late life as a suicide prevention strategy, with attention to real-world implementation and reach.

What kinds of service settings or partners are mentioned as relevant?

Examples include healthcare systems, community-based aging services, faith-based organizations, public housing settings, telehealth and digital supports, peer or lay navigator programs, and integrated care approaches that connect older adults to social resources.

Is the program oriented toward prevention or treatment?

The opportunity emphasizes prevention-oriented models that can be implemented in real-world settings, particularly models aimed at strengthening social connection to reduce suicide risk in late life.

What does NIH mean by focusing on real-world implementation and reach?

The announcement highlights the importance of how programs reach socially disconnected older adults and how services can be adapted to different communities, implying attention to practical delivery, engagement, and adaptation across settings.

What grant mechanism is being used?

This opportunity uses the NIH R21 mechanism, which generally supports exploratory or developmental research.

What kind of projects are a good fit for an R21 in this program?

Innovative, early-stage, or proof-of-concept projects are the best fit. The announcement describes studies that generate strong preliminary evidence, establish feasibility, validate targets or measures, or open up a new line of inquiry related to social disconnection and late-life suicide risk.

Does the provided information specify an award ceiling or number of awards?

No. The source information provided does not specify an award ceiling or the expected number of awards. It notes that the R21 format is typically intended to support focused, high-impact studies that can later be scaled or followed by larger research.

Who is eligible to apply?

Eligibility is broad. It includes many domestic organizations and governments as well as additional categories explicitly listed in the announcement, including certain designated institutions, community organizations, and non-U.S. entities.

Which U.S. government entities are eligible?

Eligible domestic government applicants include state governments, county governments, city or township governments, and special district governments.

Are educational institutions eligible?

Yes. Eligible applicants include independent school districts, public and state-controlled institutions of higher education, and private institutions of higher education.

Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are eligible, and tribal organizations that are not federally recognized governments are also listed as eligible.

Are housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are included in the eligible applicant types.

Are nonprofit organizations eligible?

Yes. Nonprofits with or without 501(c)(3) status (other than institutions of higher education) are eligible, and the announcement also calls out faith-based or community-based organizations as eligible applicant categories.

Are for-profit organizations eligible?

Yes. For-profit organizations other than small businesses are eligible, and small businesses are also eligible.

Are U.S. territories eligible?

Yes. The announcement lists U.S. territories or possessions and regional organizations among eligible applicant categories.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The announcement explicitly includes non-U.S. entities (foreign organizations) as eligible applicants.

Are specific institution types explicitly called out as eligible?

Yes. The announcement explicitly calls out Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).

Are federal agencies eligible?

Yes. The announcement includes eligible federal agencies among additional eligible applicant categories.

What is the funding opportunity number and CFDA listing provided?

The Funding Opportunity Number is PAR-25-066 and the CFDA number provided is 93.242.

What are the key dates listed in the provided information?

The creation date is November 18, 2024, and the original closing date is September 7, 2026.

What kinds of outcomes or endpoints are relevant to this opportunity?

Relevant outcomes include suicidal ideation, suicidal thoughts and behaviors, self-harm risk factors, and related clinical endpoints, particularly when the study is testing whether changing a target leads to changes in suicide-related risk.

How does this opportunity link biology, environment, and service delivery?

The announcement encourages studies that connect neurobiological processes (such as stress or inflammation) with environmental and contextual factors (such as bereavement, disability, poverty, discrimination, or service barriers) and translate those insights into interventions or service models designed to strengthen social connection and prevent suicide in late life.

What is the overall "fit" NIH appears to be looking for?

Mechanism-informed, prevention-focused research on late-life suicide risk related to social isolation and loneliness, ideally including measurable targets and clear pathways to intervention and/or scalable service delivery models in real-world settings.